Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-17-015990

VP, Finance sold 161 shares at $2.56 ($412)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Selby Brian L. VP, Finance 2017-02-27 Sale −161 $2.56 $412 2,389 D
Derivatives
Selby Brian L. VP, Finance 2017-02-27 Grant or award · Stock Option (right to buy) +24,100 24,100 D
Open-market sales · 161 sh · avg $2.56 · $412
Loading xslF345X03/doc4.xml…